| Revenue | NOK 15,5M | -17% |
| EBITDA | NOK 429K | +321% |
| Net profit | NOK -147K | +65% |
| Total assets | NOK 7,6M | +9% |
| Equity | NOK 2,1M | -7% |
| Employees | 5 | — |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 371 | 6 990 | 7 286 | 8 755 | 12 290 | 14 008 | 22 875 | 18 644 | 15 531 |
| Staff expenses | −485 | −2 936 | −3 018 | −3 688 | −4 296 | −4 858 | −6 598 | −7 110 | −6 319 |
| EBITDA | 77 | 65 | 103 | −257 | 473 | 208 | 2 721 | −194 | 429 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −8 | −127 | −338 | −292 |
| EBIT | 77 | 65 | 103 | −257 | 473 | 200 | 2 594 | −532 | 138 |
| Net financials | 1 | 2 | 19 | 5 | 1 | −14 | −3 | −5 | −256 |
| Profit before tax | 77 | 67 | 122 | −251 | 474 | 186 | 2 591 | −538 | −118 |
| Tax | 18 | 29 | 17 | −55 | 104 | 43 | 565 | −117 | 29 |
| Net profit | 59 | 38 | 105 | −196 | 369 | 143 | 2 027 | −420 | −147 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 975 | 6 317 | 9 989 | 11 192 | 13 314 | 17 664 | 12 345 | 6 943 | 7 566 |
| Equity | 144 | 182 | 287 | 91 | 460 | 603 | 2 630 | 2 210 | 2 063 |
| Long-term debt | 0 | 5 000 | 9 001 | 9 000 | 9 000 | 9 006 | 6 116 | 2 109 | 2 205 |
| Short-term debt | 1 831 | 1 135 | 702 | 2 101 | 3 854 | 8 055 | 3 598 | 2 624 | 3 298 |
| Total debt | 1 832 | 6 135 | 9 702 | 11 101 | 12 854 | 17 061 | 9 714 | 4 733 | 5 504 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AT Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
EN Chief Executive Officer | Chief Executive Officer | 2017 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2026 | — | — | |
| Board of Directors | 2026 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Inven2 As | Company | 33.3% | 33.3% | 2024 |
Norway Health Tech | Company | 33.3% | 33.3% | 2024 |
Oslotech As | Company | 33.3% | 33.3% | 2024 |
| Person | Role here | Other companies |
|---|---|---|
| Aksel Tunold | Chief Executive Officer | 0 companies |
| Erling Nordbø | Chief Executive Officer | 0 companies |
| Ole Kristian Hjelstuen | Board of Directors | 0 companies |
| Guro Bjøntegaard | Board of Directors | 0 companies |
| Håvard Selby Ebbestad | Board of Directors | 0 companies |
| Iacob Mathiesen | Board of Directors | 0 companies |
| Hans-Peter Hygen Daae | Chairman | 0 companies |
| Leila Yousif Circhirillo | Board of Directors | 0 companies |